Fluoroquinolone‐related hypoglycaemia is rare but may become clinically relevant in individuals at high baseline hypoglycaemic risk, such as patients with diabetes using sulphonylureas. Our population‐based cohort study assessed whether fluoroquinolones… Click to show full abstract
Fluoroquinolone‐related hypoglycaemia is rare but may become clinically relevant in individuals at high baseline hypoglycaemic risk, such as patients with diabetes using sulphonylureas. Our population‐based cohort study assessed whether fluoroquinolones are associated with an increased risk of severe hypoglycaemia compared with amoxicillin among patients treated with sulphonylureas.
Keywords:
based cohort;
risk;
cohort study;
population based;
severe hypoglycaemia;
risk severe
Journal Title: Diabetes
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!